Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (1166)	1/16/2001 3:15:19 PM
From: Madharry	Read Replies (1) \| Respond to of 1386

Could someone enlighten me as to how this study is to work? my lack of understanding relates to the predictability of a sudden brain injury requiring an injection within 6 hours. Is it not hard to get approval ahead of time for such an injection? and is it not of questionable ethics to try to get the permission of someone who has just had head trauma or a stroke? Also if this is such a wonderful thing how is it that it is apparent to all the pars investors but not to any of the drug companies?